Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 97.37 USD -0.47% Market Closed
Market Cap: 4.7B USD
Have any thoughts about
Axsome Therapeutics Inc?
Write Note

Axsome Therapeutics Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Axsome Therapeutics Inc
Depreciation & Amortization Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Axsome Therapeutics Inc
NASDAQ:AXSM
Depreciation & Amortization
$7m
CAGR 3-Years
516%
CAGR 5-Years
169%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Depreciation & Amortization
$7.3B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
6%
Bristol-Myers Squibb Co
NYSE:BMY
Depreciation & Amortization
$10.2B
CAGR 3-Years
-2%
CAGR 5-Years
72%
CAGR 10-Years
34%
Pfizer Inc
NYSE:PFE
Depreciation & Amortization
$6.7B
CAGR 3-Years
11%
CAGR 5-Years
1%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Depreciation & Amortization
$4.3B
CAGR 3-Years
9%
CAGR 5-Years
3%
CAGR 10-Years
-5%
Eli Lilly and Co
NYSE:LLY
Depreciation & Amortization
$1.7B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
2%

See Also

What is Axsome Therapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
7m USD

Based on the financial report for Jun 30, 2024, Axsome Therapeutics Inc's Depreciation & Amortization amounts to 7m USD.

What is Axsome Therapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
169%

Over the last year, the Depreciation & Amortization growth was 4%. The average annual Depreciation & Amortization growth rates for Axsome Therapeutics Inc have been 516% over the past three years , 169% over the past five years .

Back to Top